About Corstasis Therapeutics

Clinical stage pharmaceutical company advancing innovative outpatient options for patients suffering from fluid overload (edema) associated with congestive heart failure(CHF), liver, and kidney disease.

Company Highlights
Year Founded

2018

icon-altEmployees

2

Location (HQ)

USA

Since Last Funding

1 year 2 months

Monthly Website Visitors

516

Last Funding Round

Series Unknown

Key Metrics

Senior Hires

NameLinkedin ProfilePositionDate Joined
John Doehttps://www.linkedin.com/in/johndoeCEOCEO
Jane Doehttps://www.linkedin.com/in/janedoeCTOCTO
John Smithhttps://www.linkedin.com/in/johnsmithCFOCFO
Jane Smithhttps://www.linkedin.com/in/janesmithCOOCOO
Get API access to complete private company database with growth metrics from 15 sources

Health Care

Pharmaceutical Manufacturing

Home Health Care

Therapeutics

Outpatient Care